Sixteen-membered macrocycle 3 and 16+14
bicyclic compound 4, incorporating a terminal
primary
hydroxyl group in the peptide sequence, have been designed and
synthesized. The syntheses feature
the use of an efficient cycloetherification based on an intramolecular
SNAr reaction for the formation
of biaryl ether bonds. Cyclization of linear tetrapeptide
30, prepared via a convergent [2+2] segment
coupling between 26 and 29, gave macrocycle
31 (P configuration) as a single isolable
atropisomer.
Removal of the Boc protecting group afforded the modified carboxyl
binding pocket of vancomycin
3. A sequential 2-fold intramolecular
SNAr reaction has been used to construct the model
bicyclic
system (i.e. 4) of the
D-O-E-F-O-G ring of
teicoplanin. Cyclization conditions (CsF, DMF, room
temperature) are sufficiently mild that the configuration of the
racemization-prone arylglycine
residue was not affected. Chiral building blocks such as
d-(1R)-[2-[(tert-butyldimethylsilyl)oxy]-1-[3-(allyloxy)phenyl]ethyl]amine 16, and
l-(S)-N-Boc-[3-(isopropyloxy)phenyl]glycine
(32) were
synthesized employing Evans' asymmetric azidation method, while
l-(S)-4-fluoro-3-nitrophenylalanine methyl ester 23 was prepared using
Schöllkopf's bislactim ether as chiral glycine
template.
Compound 3 showed interesting conformational properties
compared to vancomycin and its binding
with Ac-d-Ala was studied by NMR titration experiments.
A dissociation constant (K
d = 5 ×
10-4)
was calculated by a curve fitting method. Compound 4 is
currently the most advanced synthetic
intermediate toward the total synthesis of teicoplanin.